Corporate Banner
Satellite Banner
Technology Networks Header
Friday, December 19, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Fluorescence-based Mitochondria / Metabolism Assays
Friday, November 14, 2014
Strategic marketing agreement with Luxcel to distribute 96- and 384-well phosphorescence and fluorescence based assays.

Olympus DSX100 Opto-Digital System
Thursday, November 13, 2014
Offers biological imaging with smartphone ease.

Top Ten Pharma Uses Time Saving Fill-it System in Biologics Manufacturing
Friday, November 07, 2014
To assure consistent quality cell banks and reference standards at half the cost.

Bringing Images to Life with CellSens 1.12
Tuesday, October 28, 2014
New Olympus imaging software offers new functions and support for the latest microscopy hardware and life science researchers can now observe and react to the most elusive events taking place within biological samples.

Crisp and Fluid Imaging for Every Need - Olympus Full HD Cameras
Wednesday, October 22, 2014
Introducing the 5 megapixel DP27 and 3 megapixel DP22, Olympus presents its next generation of digital cameras for microscopy.

E-Learning: Bioreactors Made Easy!
Wednesday, October 22, 2014
The new Bioreactor Cultivation Video Guide from INFORS HT illustrates the operational steps using the Minifors and Labfors bench-top bioreactors as examples.

Blood-Derived Products for Personalized Medicine Research
Tuesday, October 21, 2014
Blood-derived products includes whole blood, serum, plasma, buffy coat and peripheral blood mononuclear cells.

FUJIFILM Diosynth Biotechnologies Announces the Launch of ‘Apollo™’
Thursday, October 09, 2014
New mammalian expression platform designed to create a robust ‘manufacturing-ready’ cell line.

Bio-Rad Introduces the New ZOE™ Fluorescent Cell Imager
Saturday, October 04, 2014
Fluorescence microscopy now as easy as using a tablet.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 262
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.

SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn